相关实验视频

Updated: May 27, 2025

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Phenotyping Mouse Pulmonary Function In Vivo with the Lung Diffusing Capacity

Published on: January 6, 2015

推进与α1抗素缺乏相关的肺病理的理解和治疗

Alice M Turner¹, Joachim H Ficker², Andrea Vianello³

¹Institute of Applied Health Research, University of Birmingham, Birmingham, UK.

Therapeutic advances in respiratory disease

|February 21, 2025

概括

阿尔法1抗素缺乏症 (AATD) 是一种遗传性疾病,导致肺气. 了解AATD病变,生物标志物和治疗的进展对于改善患者的治疗结果和生活质量至关重要.

科学领域:

肺部医学肺部医学
遗传学是一个遗传学.
生物化学生物化学

背景情况:

阿尔法1抗素缺乏症 (AATD) 是一种影响阿尔法1抗素 (AAT) 水平或功能的遗传疾病.
低或功能障碍的AAT使个体易患肺部并发症,主要是肺气.
疾病的进展受基因型和吸烟等危险因素的影响.

研究的目的:

在AATD中讨论新兴知识和未解决的问题.
专注于疾病的发病,生物标志物,临床终点和治疗障碍.
改善对与AATD相关的肺部疾病的理解和治疗.

主要方法:

审查关于AATD病原学的当前研究.
讨论诊断和治疗反应的潜在生物标志物.
对统一治疗和患者自我管理的障碍的分析.

主要成果:

AATD的发病过程复杂,涉及蛋白酶-抗蛋白酶失衡和炎症.
生物标志物可能有助于解决不足诊断和评估治疗疗效.
诊断不足和获得治疗是重大障碍.

结论:

需要进一步了解AATD病原和炎症.
生物标志物和改善治疗准入是改善患者治疗结果的关键.
赋予患者自我管理的权力可以提高生活质量.

关键词:

这就是AAT AAT AAT 在 AATDD 加入慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.在 FEV1 中,FEV1 是 FEV1.在 SERPINA1 基因中,在阿尔法1抗素.阿尔法1抗素缺乏症治疗的障碍治疗的障碍生物标志物生物标志物临床终点临床终点疾病管理疾病管理疾病的发病因子疾病的发病因子突发性质炎症是什么意思遗传变异是一种遗传变异.罕见病是一种罕见的疾病.

更多相关视频

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Implantation of Fibrin Gel on Mouse Lung to Study Lung-specific Angiogenesis

Published on: December 21, 2014

相关概念视频

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

Chronic Obstructive Pulmonary Disease-V: Management

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation

Acute Respiratory Failure-V

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.